Pfizer赞助的临床试验
总计1758个结果
-
NCT04606446招聘中条件：局部晚期或转移性 ER+ HER2- 乳腺癌, 局部晚期或转移性去势抵抗性前列腺癌, 局部晚期或转移性非小细胞肺癌
-
NCT05261139招聘中
-
NCT05544786已完成
-
NCT05139680尚未招聘条件：遗传性转甲状腺素蛋白淀粉样变性 (ATTRv) 心肌病 (CM)，混合表型
This page was automatically translated and accurateness of translation is not guaranteed. Please refer to the English version for a source text.